Advertisement
Advertisement
June 16, 2022
Artio Medical’s Financing Will Support Development of Peripheral Vascular Products
June 16, 2022—Artio Medical, Inc., which is focused on devices for the peripheral vascular, neurovascular, and cardiology markets, announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
According to the company, funds will be used to support commercialization in the United States for the recently cleared Solus Gold embolization device and to accelerate the development of Artio’s portfolio of products, including expanding the company’s engineering and manufacturing capabilities.
For the peripheral vascular market, the company is currently developing 10 products, including the Solus Gold and Solus Flex embolization devices for peripheral vessel occlusion and the Amplifi vein dilation system, which is designed to prepare hemodialysis patients for arteriovenous fistula vascular access site creation.
Artio is also developing four products for the neurovascular market, including the Endura embolization system, comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Advertisement
Advertisement
